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ABSTRACT Mice harboring a mutation in the gene encoding gastric intrinsic factor (Gif), a protein essential for the absorption
of vitamin B12/cobalamin (Cbl), have potential as a model to explore the role of vitamins in infection. The levels of Cbl in the
blood ofGif tm1a/tm1a mutant mice were influenced by the maternal genotype, with offspring born to heterozygous (high Cbl, F1)
mothers exhibiting a significantly higher serum Cbl level than those born to homozygous (low Cbl, F2) equivalents. Low Cbl lev-
els correlated with susceptibility to an infectious challenge with Salmonella enterica serovar Typhimurium or Citrobacter roden-
tium, and this susceptibility phenotype was moderated by Cbl administration. Transcriptional andmetabolic profiling revealed
that Cbl deficient mice exhibited a bioenergetic shift similar to a metabolic phenomenon commonly found in cancerous cells
under hypoxic conditions known as theWarburg effect, with this metabolic effect being exacerbated further by infection. Our
findings demonstrate a role for Cbl in bacterial infection, with potential general relevance to dietary deficiency and infection sus-
ceptibility.
IMPORTANCE Malnutrition continues to be a major public health problem in countries with weak infrastructures. In communi-
ties with a high prevalence of poor diet, malnourishment and infectious disease can impact vulnerable individuals such as preg-
nant women and children. Here, we describe a highly flexible murine model for monitoring maternal and environmental influ-
ences of vitamin B12 metabolism.We also demonstrate the potential importance of vitamin B12 in controlling susceptibility to
bacterial pathogens such as C. rodentium and S. Typhimurium.We postulate that this model, along with similarly vitamin defi-
cient mice, could be used to further explore the mechanisms associated with micronutrients and susceptibility to diseases,
thereby increasing our understanding of disease in the malnourished.
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Clinical and epidemiological studies have demonstrated an as-sociation ofmalnutrition, dietary deficiency, and infection (1,
2). Infections are more frequent and can be more chronic in pri-
mary malnourished individuals (2, 3), with evidence suggesting
that infection further weakens the host by reducing nutrient up-
take and impeding the ability to mount an effective immune
response (4–6).However, relatively little is known about the phys-
iological and immunological signatures linking general malnutri-
tion or specific dietary deficiencies to infection susceptibility.
Vitamin B12 (cobalamin [Cbl]) serves as an essential cofactor
in the cellular growth of most prokaryotic organisms. While bac-
terial species such as Escherichia coli and Salmonella enterica have
the ability to produce Cbl de novo anaerobically, mammals obtain
Cbl exclusively from animal protein dietary sources (7). Mamma-
lian Cbl absorption is a highly specific process, with the secreted
protein gastric intrinsic factor (Gif) being responsible for trans-
porting Cbl through the small intestine and facilitating endocyto-
sis in the distal ileum (8). In humans, Cbl deficiency is linked to a
variety of clinical conditions, includingmegaloblastic anemia, op-
tic atrophy, degeneration of the spinal cord, renal abnormalities,
and malabsorption (8–11). The impact of Cbl deficiency is likely
multifactorial, as it normally plays a role in cellular metabolism
with DNA stress, cellular oxidative damage, alterations in odd-
chain fatty acid and cholesterol synthesis, and anaplerosis as con-
sequences (8, 12–15).
We have recently shown that mice lacking Gif exhibit signifi-
cant growth retardation and low bone mass, with the penetrance
of this phenotype showing maternal influences (16). Here we
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characterize the susceptibility of this mouse line to different infec-
tion challenges, highlighting maternal and metabolic influences
on serum Cbl levels and susceptibility.
RESULTS
Gif-deficient mice were identified as part of a high-
throughput screen as susceptible to a bacterial challenge. By
high-throughput screening, we challenge small groups of novel
reporter-tagged knockout mouse lines with different pathogens
(17) (http://www.mousephenotype.org). One of the lines we
screened harbored a defined mutation in the gene encoding
Gif, a glycoprotein regulating the highly specific intestinal en-
docytosis of Cbl. Gif tm1a/tm1a mice exhibit altered susceptibility
to both S. enterica serovar Typhimurium and Citrobacter roden-
tium challenges (http://www.mousephenotype.org/data/genes/
MGI:1202394). These Gif mutant mice were generated on a
C57BL/6N background by using a knockout first promoter-
driven allele targeting Gif intron 5 on chromosome 19 (see
Text S1 in the supplemental material for further details). Transcrip-
tional and immunohistological analyses showed that Gif expression
was abolished in Gif tm1a/tm1a mice and restricted to the stomachs of
wild-typemice (16) (Fig. 1a shows the immunohistochemical analy-
sis results obtained).
Subsequent breeding identified two phenotypically distinct
types of Gif tm1a/tm1a mice. F1 Gif tm1a/tm1a mice resulting from
Giftm1a/  Giftm1a/ matings (Fig. 1b) were indistinguishable
from heterozygousGiftm1a/mice or their wild-type counterparts
with respect to multiple characteristics, including their suscepti-
bility to either an S. Typhimurium or a C. rodentium challenge
(data not shown). In contrast, F2 Gif tm1a/tm1a mice that resulted
fromGif tm1a/tm1aGif tm1a/tm1amatings exhibited stunted growth
(Fig. 1b and c) and enhanced susceptibility to both S. Typhimu-
rium and C. rodentium challenges. We therefore examined these
phenotypic characteristics further.
FIG 1 Gif tm1a/tm1amice exhibit signatures of Cbl deficiency. (a) Immunofluorescence analysis of the glandular stomach regions of wild-type (i) andGif tm1a/tm1a
(ii) mice stained (red) for the presence of Gif with specific antiserum (400 magnification). (b) Representative photograph of 8-week-old Gif tm1a/tm1a and
wild-type pups from Gif tm1a/tm1a (left), Giftm1a/(middle), or wild-type (right) dams. (c) Mean body weights of F1 Gif tm1a/tm1a (red triangles), F2 Gif tm1a/tm1a
(purple triangles), andwild-type (blue circles)mice between 3 and 16weeks of age. (d) Blood plasmaCbl concentrationsGif tm1a/tm1a andwild-typemice. Dashed
lines show the detection limits of the analyzer. Black bars represent geometric mean values. ***, P  0.001; **, P  0.01; *, P  0.05 (ANOVA with Dunn’s
multiple-comparison post hoc test).
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F2 Gif tm1a/tm1a mice are deficient in Cbl and have altera-
tions in red blood cell and plasma chemistry. To ascertain if
Gif tm1a/tm1a mice were Cbl deficient, we measured the blood
plasma Cbl concentrations of wild-type and Gif tm1a/tm1a mice
(Fig. 1d). We found that all of the wild-type mice exhibited high
plasma Cbl concentrations (2,000 ng/liter), with F1 Gif tm1a/tm1a
mice showing various levels of blood plasmaCbl deficiency. How-
ever, blood plasma from F2 Gif tm1a/tm1a mice consistently exhib-
ited at least 20-fold lower Cbl levels than that from their wild-type
counterparts (Fig. 1d). Further blood analysis showed that naive
F2 Gif tm1a/tm1a mice exhibited phenotypes similar to those of hu-
mans with severe Cbl deficiency (9, 11), with these F2 mice having
consistently lower erythrocyte counts (see Fig. S1b, part i, in the
supplemental material) and a greater mean corpuscular volume
(MCV; see Fig. S1b, part ii) than equivalent F1 Gif tm1a/tm1a and
wild-typemice.Moreover,megakaryocytes found in the spleens of
F2 Gif tm1a/tm1a mice were often hyperlobulated with hyperseg-
mented nuclei indicative of cell cycle irregularities compared to
wild-type cells (see Fig. S1a) (11).
Furthermore, in comparison to blood plasma collected from
equivalent F1 Gif tm1a/tm1a and wild-type mice, blood plasma from
F2 Gif tm1a/tm1a mice exhibited alterations in multiple clinical
chemistry parameters (Fig. S1c). We observed that the concentra-
tions of iron, high-density lipoproteins, cholesterol, as well as al-
bumin, glucose, and glycerol, were significantly lower in the blood
plasma of F2Gif tm1a/tm1a mice (Fig. S1c, parts i to vi). Interestingly
the level of urea, a clinical marker ofmuscle damage, was found to
be significantly higher in the blood plasma of F2 Gif tm1a/tm1a mice
than in that of F1Gif tm1a/tm1a andwild-typemice (see Fig. S2c, part
vii, in the supplemental material).
F2 Gif tm1a/tm1a mice are hypersusceptible to C. rodentium
and S. Typhimurium challenges.When groups of F2 Gif tm1a/tm1a
andwild-typemice were challengedwithC. rodentium, 60%of the
F2 Gif tm1a/tm1a mice succumbed to infection by day 14 postinfec-
tion (p.i.), compared to none of the wild-type mice (Fig. 2a, part
i). Although the enumeration ofC. rodentiumwas statistically sig-
nificantly higher in all of the organs of the challenged F2 Gif tm1a/
tm1a mice than in the challenged wild-type mice at day 14 p.i.
(Fig. 2a, part ii), the two groups had similar colon weights and
general patterns of colonic hyperplasia (see Fig. S2 in the supple-
mental material). Significantly, however, C. rodentium was con-
sistently found (P  0.001) in the livers of F2 Gif tm1a/tm1a mice
(Fig. 2a, part ii). Furthermore, other bacterial taxa, such as Staph-
ylococcus and Escherichia, were also present in their livers, suggest-
ing that polymicrobial sepsis was occurring after a C. rodentium
challenge in these F2 Gif tm1a/tm1a mice (data not shown). Impor-
tantly, bacteria were not generally detected in the livers of wild-
type mice before or after a C. rodentium challenge.
Similar groups of wild-type and F2 Gif tm1a/tm1a mice were also
challengedwithmoderately attenuated S. TyphimuriumM525. F2
FIG 2 F2 Gif tm1a/tm1a mice are susceptible to C. rodentium and S. Typhimurium pathogen challenges. (a, part i) Kaplan-Meier curve showing percent survival
following infection of F2Gif tm1a/tm1a and wild-typemice withC. rodentium (n 8). (a, part ii) Enumeration ofC. rodentium bacteria in cecal, colon, spleen, and
liver tissues of surviving F2 Gif tm1a/tm1a and wild-type mice at day 14 p.i. (b, part i) Kaplan-Meier curve showing percent survival following infection of F2
Gif tm1a/tm1a and wild-type mice with S. Typhimurium (n 8). (b, part ii) Enumeration of S. Typhimurium bacteria in the spleens and livers of F2 Gif tm1a/tm1a
andwild-typemice at day 14 p.i. Gray circles represent wild-typemice. Black triangles represent F2Gif tm1a/tm1amice. Black bars represent geometricmean values.
***, P 0.001; **, P 0.01; *, P 0.05 (ANOVA with Dunn’s multiple-comparison post hoc test).
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Gif tm1a/tm1a mice showed signs of salmonellosis by day 4 p.i., with
all mice having to be sacrificed between days 6 and 14 p.i. (Fig. 2b,
part i). In contrast, wild-type mice exhibited little sign of disease
and survived the challenge. Interestingly, the S. Typhimurium
burdens in the spleens and livers of F2 Gif tm1a/tm1a and wild-type
mice were comparable at day 14 p.i. (Fig. 2b, part ii). Thus, over-
whelming S. Typhimurium burdens were unlikely to be responsi-
ble for the disease in F2 Gif tm1a/tm1a mice.
Histopathological signatures are observed in F2 Gif tm1a/tm1a
mice before and after a pathogen challenge. A detailed histo-
pathological analysis of tissues from naive and pathogen chal-
lenged F2 Gif tm1a/tm1a and wild-type mice was performed. The
general colonic and splenic morphology of naive F2 Gif tm1a/tm1a
mice was predominantly indistinguishable from that of wild-type
mice (see Fig. S3a and b in the supplementalmaterial). In contrast,
F2 Gif tm1a/tm1a mouse livers had hepatocytes with enlarged nuclei
and abnormal mitotic figures (Fig. 3a, part ii), indicating liver cell
karyomegaly and mitotic impairment (18).
Althoughmoderate inflammation and colonic pathology were
present in wild-type mice at day 14 after a C. rodentium challenge
(Fig. 3b, part i), F2 Gif tm1a/tm1a mice developed a more severe
epithelial inflammatory cell infiltration, accompanied by crypt ab-
scesses containing neutrophils and intraepithelial lymphocytes in
the mucosa and increased inflammation in the submucosa
(Fig. 3b, part ii, for a higher magnification, and Fig. S3c, part i, in
the supplemental material). Moreover, while the livers of wild-
type mice challenged with C. rodentium showed no obviously en-
hanced inflammatory cell infiltrate, challenged F2 Gif tm1a/tm1a
mice exhibited rich inflammatory clusters particularly around the
hepatic portal triad, with a thrombus occasionally present within
the hepatic portal vein (see Fig. S3c, part ii).
The liver histology of F2 Gif tm1a/tm1a mice challenged with
FIG 3 Representative hematoxylin- and eosin-stained sections from naive and infected F2 Gif tm1a/tm1a and wild-type mice. (a) Liver sections from naive
wild-type (i) and F2 Gif tm1a/tm1a (ii) mice. A single asterisk indicates an abnormal mitotic figure, and double asterisks indicate enlarged cellular nuclei in an F2
Gif tm1a/tm1a mouse (400magnification). (b) Colon sections obtained on day 14 after aC. rodentium challenge of wild-type (i) and F2Gif tm1a/tm1a (ii) mice. The
asterisk indicates a crypt abscess in an F2 Gif tm1a/tm1a mouse (100 magnification). (c) Liver sections obtained on day 8 after an S. Typhimurium challenge of
wild-type (i) and F2 Gif tm1a/tm1a (ii) mice. Both images show inflammatory cellular infiltration and granuloma formation. Asterisks indicate the large necrotic
regions seen in F2 Gif tm1a/tm1a mice ( 200 magnification).
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S. Typhimurium exhibited evidence of significantly more damage
than that of wild-typemice (Fig. 3c). Both groups of infectedmice
harbored clusters of macrophages forming granulomas; however,
there were sizable areas of necrosis and regions of foamy fatty acid
hepatocytes (fat vacuoles indicatingmetabolic stress) in the S. Ty-
phimurium challenged F2 Gif tm1a/tm1a mice (Fig. 3c, part ii). The
spleens of wild-type S. Typhimurium infected mice displayed a
normal distribution of red and white pulp, but similarly chal-
lenged F2 Gif tm1a/tm1a mice exhibited increased extramedullary
hematopoiesis with scattered large areas of necrosis with foci of
macrophages in the red pulp compacting the white pulp (see
Fig. S3d in the supplemental material).
Immune profiling of naive and S. Typhimurium infected F2
Gif tm1a/tm1a mice. We performed immune profiling before and
after a challenge to identify immunological signatures associated
with F2Gif tm1a/tm1a mouse susceptibility to S. Typhimurium (19).
While we found that the percentages of peripheral blood phago-
cytes and natural killer cells were broadly comparable (http://
www.mousephenotype.org/data/genes/MGI:1202394), we did
observe slight differences in the percentages of peripheral blood
CD4 and CD8 T cells and CD4 CD25 regulatory T cells
(Fig. 4a, part ii, and Fig. S4a in the supplemental material) in F2
Gif tm1a/tm1a mice and equivalent populations found in wild-type
mice. However, when spleen leukocyte populations were analyzed
at day 9 after S. Typhimurium infection, F2 Gif tm1a/tm1a mouse T
cell populations (Fig. 4b), as well as all of the other lymphocyte
populations analyzed (see Fig. S4b), were comparable to those of
similarly infected wild-typemice. Similarly, blood serum cytokine
and chemokine analysis revealed no obvious differences between
the concentrations of 25 different cytokines found in naive or
infected F2 Gif tm1a/tm1a mice and those in wild-type mice (see
Text S1 in the supplemental material for further details).
As macrophages are critical for the control of Salmonella rep-
lication and the homeostasis of granulomas in vivo (20, 21), we
isolated macrophages from the peritoneal cavities of naive F2
Gif tm1a/tm1a and wild-type mice to evaluate their susceptibility to
S. Typhimurium.We found that the ability of F2Gif tm1a/tm1amac-
rophages to kill S. Typhimurium was not impaired and was com-
parable to that of wild-type macrophages. Interestingly, we found
that F2 Gif tm1a/tm1a macrophages expressed higher levels of argi-
nase 1 (see Fig. S4c in the supplemental material), a marker of
alternatively activated M2 macrophages (6, 22).
Transcriptional profiling indicates potential cellular, meta-
bolic, and anaplerosis pathway abnormalities in F2 Gif tm1a/tm1a
mice. To identify changes in gene expression that could have an
impact on the phenotype of F2Gif tm1a/tm1a mice, microarray anal-
ysis was performed with mRNA prepared from the livers and co-
lons of F2Gif tm1a/tm1a andwild-typemicewith orwithout a patho-
gen challenge. Genes differentially expressed (P  0.05 with a
0.8-log-fold difference between F2 Gif tm1a/tm1a and wild-type
mice) under each condition were further analyzed by Ingenuity
Pathway Analysis (IPA; Qiagen, Redwood City, CA), enabling the
FIG 4 Immune cell profiling of naive and S. Typhimurium-challenged F2 Gif tm1a/tm1a and wild-type mice. (a) Analysis of peripheral blood leukocytes from
16-week-old naive mice showing percentages of CD3 (i) and CD4 (ii) T cells. (b) Analysis of spleen cells from S. Typhimurium-infected mice on day 14 p.i.
for total CD3 (i) and total CD4 (ii) T cells. Samples were analyzed on a BD LSR Fortessa or BD LSR II apparatus. Interpretation of the results was performed
with FlowJo v9. Black bars represent geometric mean values. *, P 0.05 (one-way ANOVA followed by Dunn’s multiple-comparison post hoc test).
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clustering of dysregulated mRNAs to specific biological and ca-
nonical pathways. Further, IPA upstream regulator analysis was
used to predict potential upstream transcriptional regulators
likely controlling these biological function and canonical path-
ways in the transcriptional data of the F2 Gif tm1a/tm1a mice.
Generally, differentially expressed genes in the colons of naive
F2 Gif tm1a/tm1a mice were related to lipid metabolism, cell-to-cell
signaling, molecular transport, small molecule biochemistry, and
cell death and survival processes (see Dataset S1b in the supple-
mental material). Upstream regulator analysis predicted that
genes associated with glycolysis regulation (Por, Clock, Cry1, and
Cry2) (23, 24) (see Dataset S1a) might be controlling the func-
tional gene profile in the colons of naive F2 Gif tm1a/tm1a mice.
Functional gene categories in the livers of naive F2 Gif tm1a/tm1a
mice were largely associated with lipid, vitamin, mineral, and nu-
cleic acid metabolism, as well as cellular molecular transport (see
Dataset S1c), with upstream regulator analysis predicting glycol-
ysis and fatty acid synthesis associated genes (Gpd1, Slc25a13,
RorC, RorA, and Acox1; see Dataset S1a) as potential regulators of
disrupted cellular and biological functions in the livers of naive F2
Gif tm1a/tm1a mice. In particular, Acox1 (encodes acyl coenzyme A
[acyl-CoA] oxidase 1, palmitoyl), a peroxisome beta-oxidation
fatty acid pathway regulator (25, 26), was predicted by IPA to be
the most statically activated of the upstream transcriptional regu-
lators (see Dataset S1a).
Of the differently expressed genes identified in colonic mRNA
of F2 Gif tm1a/tm1a mice challenged with C. rodentium, 60 were
functionally associated with cell death and survival, with IPA pre-
dicting functional pathways associated with organismal injury
and renal failure to be the most activated of these categories (see
Dataset S1d in the supplemental material). Upstream transcrip-
tional regulator analysis highlighted Ptger4, a prostaglandin regu-
lator of mucosal integrity and suppressor of innate immunity
(27), as comparatively activated (see Dataset S1a), with Cfs2, a
modulator of epithelial cell homeostasis, as well as classical M1
macrophage activation (28, 29), as likely inhibiting canonical
pathways in the colons of C. rodentium-infected F2 Gif tm1a/tm1a
mice (see Dataset S1a). The top five functional gene categories in
hepatic mRNA of C. rodentium-infected F2Gif tm1a/tm1a mice were
predicted to be related to cellular function and maintenance,
movement, development, growth and proliferation, and signal-
ing, with our analysis showing many of these associated genes
relatively downregulated (see Dataset S1e). A key transcriptional
regulator was predicted to be Acox1 (see Dataset S1a).
Finally, IPA of the hepatic mRNA data of differentially ex-
pressed genes found in S. Typhimurium infected F2 Gif tm1a/tm1a
mice was performed (see Dataset S1a and f in the supplemental
material). Consistent with the other IPA analyses (see Data-
set S1a),Acox1was predicted to be a key regulatory element. Func-
tional and canonical pathway analysis identified differentially ex-
pressed genes as associated with lipid, drug, and carbohydrate
metabolism; small-molecule biochemistry; and cellular develop-
ment. IPA indicated that functional pathways associatedwith fatty
acid metabolism were overactivated (P  4.39e06; see Data-
set S1e).
Blood metabolic profiling identifies F2 Gif tm1a/tm1a mice as
having abnormal glycolytic pathways and cellular energy ho-
meostasis pathways. To identify metabolites that might be influ-
enced downstream of the changes in transcriptional patterns ob-
served in the tissues of F2 Gif tm1a/tm1a mice, metabotyping was
performed by nuclear magnetic resonance (NMR) spectroscopy
of blood serum taken from F2 Gif tm1a/tm1a and wild-type mice
before and after an S. Typhimurium challenge. By performing
principal component analysis (PCA), a multivariate data analysis
method, we could distinguish the blood serummetabolic profiles
FIG 5 Metabotyping of blood serum from F2 Gif tm1a/tm1a and wild-type mice reveals metabolic abnormalities. (a) PCA score plot separating naive F2
Gif tm1a/tm1amice (green circles) fromnaivewild-typemice (blue circles) with 92%of the variables explained (R2cum) by using the first four components with 72%
predictabilityminusQ2. (b)Multivariate data analysis results comparing the blood serum of uninfected F2Gif tm1a/tm1a (ui_gif; red circles) andwild-type (ui_wt;
yellow circles) mice and that of S. Typhimurium-infected F2 Gif tm1a/tm1a (si_gif; green circles) and wild-type (si_wt; blue circles) mice. Principal component 1
discriminates on the basis of the presence or absence of infection, while principal component 2 separates differentmouse genotypes, regardless of infection status.
Ninety percent of the variables (R2cum) were explained by using the first five components with 73% predictability.
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of naive (Fig. 5a), as well as S. Typhimurium infected (Fig. 5b) F2
Gif tm1a/tm1a and wild-type mice.
As expected, uninfected wild-type mice demonstrated blood
metabolic patterns of normal cellular homeostasis, harboring
higher levels of fatty acids and glucose (Table 1). In contrast, naive
F2 Gif tm1a/tm1a mice harbored a metabolic profile with similarities
to the Warburg effect (30). This profile included higher levels of
lactate and lower quantities of glucose, indicating that lactic acid
fermentation was occurring to generate energy for cellular ho-
meostasis. We also identified biomarkers of alternative cellular
energy sourcing such a decrease amount of fatty acids and an
increased quantity of citrate-aspartate, metabolites commonly as-
sociated with increased glycolysis and acetyl-CoA production
(Table 1; see Fig. S5, in the supplemental material). Furthermore,
we observed a high level of methylmalonate, a known plasma
marker of Cbl deficiency, in the blood of naive F2 Gif tm1a/tm1a
mice, suggesting that Cbl deficiency could be disrupting the tri-
chloroacetic acid (TCA) cycle (14, 15).
Next, we metabotyped blood serum from wild-type and F2
Gif tm1a/tm1a mice at day 9 after an S. Typhimurium challenge
(Fig. 5b). S. Typhimurium is known to cover its metabolic needs
during infection by upregulating host cell glycolysis and associ-
ated fatty acid beta-oxidation pathways (22, 31, 32), with the
blood of infected wild-typemice harboring relatively higher levels
of metabolites indicative of beta oxidation activity such as
3-hydroxybutyrate and butyrate and adipate (Table 1). In con-
trast, challenged F2 Gif tm1a/tm1a mice exhibited biomarkers asso-
ciated with severe changes in cellular energy homeostasis and gly-
colytic processes, as well as metabolic starvation (30, 33). We
identified lower levels of blood sugars (glucose and fucose), with
taurine (Table 1), and leucine, metabolites thought to regulate
maurine skeletal function as well as glucose and lipid homeostasis
(12, 34) reduced in the blood of infected F2 Gif tm1a/tm1a mice. We
also observed biomarkers of increased acetyl-CoA and fatty acid
synthesis (fatty acids, valine, and phenylacetylglycine), and in-
creased oxidative stress (adipate, taurine-betaine, chlorine, and
malate) (30). Furthermore, and comparative to their uninfected
F2 Gif tm1a/tm1a counterparts, the plasma Cbl marker methylma-
lonate was observed at high levels in the blood metabolite profile
of infected F2 Gif tm1a/tm1a mice (Table 1).
Cbl supplementation reverses the S. Typhimurium suscepti-
bility of F2 Gif tm1a/tm1a mice. To evaluate if F2 Gif tm1a/tm1a Cbl
deficiency was directly impacting their hypersusceptibility to
C. rodentium and S. Typhimurium infection, we supplemented F2
Gif tm1a/tm1a mice with Cbl in a series of subcutaneous injections
prior to a challenge and compared their susceptibility to an S. Ty-
phimuriumM525 challenge with that of untreated F2 Gif tm1a/tm1a
mice. As expected, untreated F2 Gif tm1a/tm1a mice showed signs of
TABLE 1 Summary of the relative metabolic differences in the blood serum of naive and S. Typhimurium-infected F2 Gif tm1a/tm1a and wild-type
micea
Metabolite(s) Chemical shift(s) (ppm)
Fold change(s)b
Naive Infected
Fatty acids Several 21.2 —,11.4c
Putrescine-cadaverine 1.75, 3.04; 1.48, 3.80 — 1
Glucose 3.24, 3.46, 3.52, 3.73; 3.83,
3.88, 5.22
21.2 21.3
Fucose 1.22, 1.25, 3.44, 3.60, 3.80,
5.25
— 21.5
Acetate 1.93 1 —
Alanine 1.49, 1.51, 3.81 1 —
Taurine-betaine 3.27, 3.44; 3.25, 3.90 1 21.3,2c
Citrate-aspartate 2.55, 2.67; 2.64, 2.70 11.2 —
Formate 8.47 1 —
Glutamate-glutamine (2.04, 2.12), (2.34, 2.39),
3.74; (2.00, 24.00, 2.48),
3.78
2 —
Isoleucine 0.98, 1.01, 3.66 2 —
Leucine 0.96, 1.72, 3.75 2 21.6
Methylmalonate 1.22, 3.18 11.3 11.2
Phenylacetylglycine 3.68, 3.76, 7.40 1 1
Valine 1.01, 1.06, 2.29, 3.61 — 1
Adipate 1.56, 2.17 — —,11.6c
3-Hydroxybutyrate 1.21, (2.32, 2.42), 4.16 — 2
Butyrate 0.89, 1.56, 2.15 — 2
Lactate 1.34, 4.13 11.2 —
Pyruvate-succinate 2.39, 2.41 1 —
Choline-phosphocholine-
glycerophosphocholine
3.20, 3.21, 3.22 — 1
Malate (2.36, 2.42), (2.66, 2.70),
4.30
— 1
a Fold change,1.2; P 0.05.
b Shown are fold (1.2) and significant (P 0.05) changes in metabolite levels in F2 Gif tm1a/tm1a and wild-type mice.
c Shown are fold (1.2) and significant (P 0.05) changes in metabolite levels in naive versus S. Typhimurium-infected F2 Gif tm1a/tm1a mice. Symbols: —, no significant fold
change (1.2);1 or2, relative increase or decrease in metabolites from PCA loading plots. These levels were estimated from relative intensities (median) of 1H NMR spectra
following spectral normalization.
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salmonellosis by day 4 p.i. and had to be sacrificed by day 7 p.i.
(Fig. 6). In contrast, equivalent Cbl-treated F2 Gif tm1a/tm1a mice
exhibited limited signs of salmonellosis, survived the challenge,
and were indistinguishable from their wild-type counterparts.
Thus, Cbl deficiency in these F2 Gif tm1a/tm1a mice is likely directly
influencing their susceptibility to S. Typhimurium infection.
DISCUSSION
By exploiting a novel Gif mutant mouse line, we have demon-
strated a critical role for Cbl in controlling susceptibility to infec-
tion by two different bacterial pathogens, C. rodentium and S. Ty-
phimurium.We link this severe phenotype to likely disruptions in
glycolysis, fatty acid synthesis, and energy homeostasis processes
in Cbl-defective mice (12, 14, 30, 31, 33), with infection suscepti-
bility further being influenced by the genotype of mothers, a phe-
nomenon linked to their ability to transfer Cbl to their offspring
(35).
The results obtained with Gif deficient mice mimic aspects of
the clinical phenotypes associated with Cbl deficiency in humans
and other mammals. For example, children born to Cbl depleted
mothers exhibit stunted growth (10), similar to that observed in F2
Gif tm1a/tm1a mice and infant rats andmice when Cbl was removed
from their diet (16, 35, 36). Further, we demonstrate how Cbl
deficiency can likely disrupt mammalian cellular homeostasis
processes. F2Gif tm1a/tm1amice exhibited blood andhistopatholog-
ical signatures associated with DNA abnormalities such as mega-
loblastic anemia, abnormal mitotic figures, and cellular oxidative
damage, phenotypes commonly associated with Cbl deficiency in
humans and infant mice (8, 9, 11, 13). By metabolomic and tran-
scriptional profiling, we also found evidence that succinyl-CoA, a
Cbl by-product and an essential TCA cycle regulator, was inhib-
ited in F2 Gif tm1a/tm1a mice, likely leading to increased glycolysis
and fatty acid synthesis and other metabolic activities commonly
associated with the Warburg effect (12–15, 30).
We were unable to detect a clear immunological signature as-
sociated with Cbl deficiency in F2 Gif tm1a/tm1a mice, even though
others have reported that Cbl deficiency affects cytokine and T cell
ratios in a uninfected host (37, 38). Clearly, we did not exhaus-
tively screen for immune deficiencies, and further studies in this
area are still warranted. However, the macrophage killing activity
that is critical for controlling salmonellosis in vivo was not obvi-
ously impaired, and immune cell populations and cytokine levels
critical for Salmonella control appeared to be broadly similar (19).
Interestingly however, and perhaps consistent with the Warburg
effect (6), we did identify signatures for alternatively activatedM2
macrophages, such as increased expression of arginase 1 by F2
Gif tm1a/tm1a mouse macrophages. We therefore concluded, like
the authors of a previously published study (22), that this meta-
bolic activation state has little impact on the control of Salmonella
replication because these cells were still able to kill salmonellae in
vitro.
After C. rodentium infection, F2 Gif tm1a/tm1a mice exhibited
polymicrobial sepsis, with an overgrowth of C. rodentium. Histo-
pathological examination revealed greater recruitment of inflam-
matory cells to the colon and liver than similarly infected wild-
type mice, with transcriptional profiling suggesting that cellular
homeostasis processes are likely disrupted in F2 Gif tm1a/tm1a mice
after C. rodentium infection. F2 Gif tm1a/tm1a mice infected with
S. Typhimurium exhibited greater signs of lethargy and morbid-
ity, with severe histopathological damage. As S. Typhimurium
utilizes the same fatty acid beta-oxidation and glycolysis pathways
that are already dysregulated in F2 Gif tm1a/tm1a mice (22, 31, 32),
we hypothesize that F2 Gif tm1a/tm1a mice are succumbing to S. Ty-
phimurium infection from metabolic starvation, with their
metabolomic and transcriptional profile strongly resembling this
scenario (33).
This study has further highlighted some of the complex clinical
and metabolomic abnormalities associated with Cbl deficiency,
demonstrating the importance of Cbl in the mammalian diet. By
performing studies on Gif tm1a/tm1a or other mice with genetic de-
fects associated with nutrient absorption, we can not only gain a
better biological understanding of the interplay between nutri-
tional regulation and the immune system but also further under-
stand the pathogenesis associated with specific nutritional dys-
regulation.
MATERIALS AND METHODS
Animals.TheGiftm1a(KOMP)Wtsimouse linewas generated on aC57BL/6N
genetic background as part of the InternationalMouse Phenotyping Con-
sortium (http://www.mousephenotyping.org). See Text S1 in the supple-
mental material for the gene targeting methods used to produce this
mouse line. Animals were housed under specific-pathogen-free condi-
tions in HEPA-filtered cages with sterile bedding and given a sterilized
standard diet and water ad libitum. All experiments were performed in
accordance with United Kingdom Animal (Scientific Procedures) Act
1986.
Hematology and blood chemistry analysis. Blood was collected un-
der terminal anesthesia into either EDTA-coated tubes or heparinized
tubes for plasma or serum preparation. Clinical chemistry analysis of
plasma was performed with the Olympus AU400 analyzer (Beckman
Coulter Ltd., High Wycombe, United Kingdom). Concentrations of Cbl
in plasma were measured with the ADVIA Centaur immunoassay ana-
lyzer (Siemens).
Cbl treatment. Mice were treated subcutaneously with cyanocobala-
min (Sigma Aldrich) at 1 mg/ml every 2 weeks for 6 weeks. Mice were left
for 1 month before an S. Typhimurium infection challenge.
Cytokine analysis. Cytokine analysis was performed with the Flex-
Map 3D (Luminex) machine with a Milliplex MapMouse Th17 Magnes-
tic Bead Panel 96-well assay kit (Millipore). For method details, as well as
a list of the cytokines analyzed, see Text S1 in the supplemental material.
Flow cytometry analysis.Analysis of peripheral blood leukocytes was
performed with heparinized blood collected from 16-week-old mice. Pe-
ripheral blood leukocytes, mesenteric lymph nodes, and spleens were pre-
pared and stained for flow cytometry analysis as described inText S1 in the
FIG 6 Cbl supplementation of F2 Gif tm1a/tm1a mice alters their susceptibility
to an S. Typhimurium challenge. Shown is a Kaplan-Meier curve of percent
survival of F2 Gif tm1a/tm1a mice left untreated or treated with cyanocobalamin
and then infected with S. Typhimurium (n 8).
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supplemental material. All samples were analyzed on an LSR II or LSR
Fortessa apparatus (BD Biosciences). Data were analyzed with FlowJo v9
software (TreeStar).
Histological analysis. For histological examination, 5-m sections of
paraffin-embedded tissues were stained with hematoxylin and eosin
(Sigma-Aldrich). Sections were examined and scored by a pathologist
under blinded conditions. For immunohistochemistry analysis, sections
were cut and fixed as described in Text S1 in the supplemental material.
Sections were visualized by confocal microscopy (Leica).
NMRanalysis.Blood serumwas collected from age- and sex-matched
mice (five per group), snap-frozen immediately, and stored at 80°C
until analysis. Samples were analyzed with a Bruker ADVANCE III NMR
spectrometer to identify metabolic differences between F2 Gif tm1a/tm1a
and wild-type mice. For further details, see Text S1 in the supplemental
material.
Microarray analysis. mRNA for microarray analysis was prepared as
described in Text S1 in the supplemental material. Analysis was per-
formedwith the IlluminaMouseWG-6 v2.0 ExpressionBeadChip kit. The
data were analyzed with BeadStudio Software (Illumina) to identify genes
differently regulated in F2 Gif tm1a/tm1a and wild-type mice. Further path-
way analysis was performed by IPA (Qiagen, Redwood City, CA) of all of
the genes differently expressed in F2Gif tm1a/tm1a and wild-typemice (P
0.05; log-fold change, 0.8). For further details of the IPA analysis per-
formed, see Text S1 in the supplemental material.
RNA isolation and RT-qPCR of peritoneal macrophages. Resident
peritoneal macrophages were isolated from naive mice by peritoneal la-
vage. RNA was isolated with the RNeasy minikit (Qiagen) and reverse
transcribed with the QuantiTect reverse transcription (RT) kit (Qiagen).
RT-quantitative PCR (RT-qPCR) experiments were performed as de-
scribed in Text S1 in the supplemental material.
Mouse infection challenges. Background matched wild-type and
giftm1a(KOMP)Wtsimice 6 to 10weeks of ageweremaintained in accordance
with United Kingdom Home Office regulations under project license
PPL80/2099 and 80/2596 (2596 replaced 2099 upon expiry). The Well-
come Trust Sanger Institute Ethical Review Committee has also reviewed
this license. For C. rodentium challenges, mice were infected orally with
0.2 ml of C. rodentium ICC180. For S. Typhimurium challenges, mice
were infected intravenously with a sublethal dose of S. Typhimurium
M525. All mice were monitored daily for defined humane endpoints in
accordance with United Kingdom Home Office license guidelines.
Measurement of pathogen burdens in organs. Organs were asepti-
cally removed and homogenized mechanically. Viable counts were deter-
mined by serially diluting the organ homogenates onto LB agar plates for
CFU counting.
Peritoneal macrophage gentamicin protection assay. Peritoneal
macrophages were infected with S. Typhimurium M525 at a multiplicity
of infection (MOI) of 20 for 1 h and then treated with gentamicin for
another hour. Cells were then washed and incubated in antibiotic-free
Opti-MEM (Thermo Fisher) for a further 5 h. For quantitative analysis,
cells were lysed in 1% Triton X-100, serially diluted, and plated onto LB
plates for CFU counting.
Statistical analysis.Where not already stated in Text S1 in the supple-
mental material, the Student t test was performed for experiments com-
paring two groups. For datawithmore than two groups, statistical analysis
was performed by a nonparametric one-way analysis of variance
(ANOVA) with Dunn’s multiple-comparison post hoc test. For compari-
sons of groups with two or more factors, analysis was performed by two-
way ANOVAwith the Bonferronimultiple-comparison posttest. P 0.05
was taken as significant in all cases. All tests were performed with Graph-
Pad Prism 5 (GraphPad Software, Inc., La Jolla, CA).
Microarray data accession numbers. The microarray data associated
with this paper are stored in the ArrayExpress public database (http://
www.ebi.ac.uk/arrayexpress) under accession numbers E-MTAB-1879
and E-MTAB-1880.
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